share_log

JP Morgan Maintains Overweight on ArcBest, Lowers Price Target to $164

Moomoo 24/7 ·  Apr 9 08:51

JP Morgan analyst Brian Ossenbeck maintains ArcBest (NASDAQ:ARCB) with a Overweight and lowers the price target from $168 to $164.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment